Skystar Bio-Pharmaceutical Company Stock
Stocks
SKBI
US8308843007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 36.7M 32.23M 29.98M 27.51M 51.69M 3.53B 52.48M 356M 139M 1.74B 138M 135M 6.01B | P/E 2012 |
1.93x | P/E 2013 | 2.56x |
|---|---|---|---|---|---|
| Enterprise Value | 39.2M 34.43M 32.02M 29.38M 55.2M 3.77B 56.06M 380M 149M 1.86B 147M 144M 6.42B | EV / Sales 2012 |
0.2x | EV / Sales 2013 | 0.69x |
| Free-Float |
100% | Yield 2012 * |
-
| Yield 2013 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Tun Qu
BRD | Director/Board Member | 60 | 2008-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 0 | ||
| +1.07% | -3.49% | -3.25% | +12.87% | 46.86B | ||
| +0.25% | +1.65% | +408.41% | +629.49% | 40.23B | ||
| -0.27% | +4.45% | +9.93% | +66.92% | 36.23B | ||
| +0.35% | +0.87% | +3.60% | -8.81% | 34.72B | ||
| +3.14% | +1.02% | +3.37% | +38.15% | 27.89B | ||
| -0.73% | +11.84% | +31.97% | +143.53% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +0.42% | -5.52% | +0.76% | +8.50% | 13.12B | ||
| -2.68% | -2.49% | -15.00% | -31.68% | 12.7B | ||
| Average | +0.20% | +0.75% | +54.97% | +107.37% | 24.53B | |
| Weighted average by Cap. | +0.48% | +0.91% | +75.32% | +136.64% |
| 2012 | 2013 | |
|---|---|---|
| Net sales | 33.59M 29.5M 27.43M 25.17M 47.3M 3.23B 48.03M 326M 127M 1.59B 126M 123M 5.5B | 42.48M 37.31M 34.7M 31.84M 59.83M 4.09B 60.75M 412M 161M 2.01B 159M 156M 6.95B |
| Net income | 6.21M 5.46M 5.07M 4.66M 8.75M 598M 8.88M 60.26M 23.54M 294M 23.32M 22.82M 1.02B | 10.53M 9.25M 8.6M 7.89M 14.83M 1.01B 15.06M 102M 39.9M 499M 39.53M 38.68M 1.72B |
| Net Debt | -5.61M -4.93M -4.58M -4.2M -7.9M -540M -8.02M -54.4M -21.25M -266M -21.05M -20.6M -918M | 2.5M 2.19M 2.04M 1.87M 3.52M 241M 3.57M 24.23M 9.47M 118M 9.38M 9.18M 409M |
Employees
-
- Stock Market
- Stocks
- SKBI Stock
Select your edition
All financial news and data tailored to specific country editions
















